Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10707324 | 0.96 | MAPK1 (0.33) | MAPK1POLBCA4ALDH1A1ALOX15 | |
| SCHEMBL191229 | 0.89 | MAPK1 (0.37) | MAPK1CA4ALDH1A1ALOX15TSHR | |
| SCHEMBL10906145 | 0.85 | — | — | |
| SCHEMBL37986 | 0.81 | CA4 (0.41) | MAPK1POLBCA4ALDH1A1KDM4E | |
| SCHEMBL1974068 | 0.79 | CA1 (0.41) | MAPK1POLBCA4ALDH1A1KDM4E | |
| Ammonia Solution, Strong SCHEMBL2330946 | 0.79 | POLB (0.39) | MAPK1POLBCA4ALDH1A1KDM4E | |
| Water SCHEMBL18606224 | 0.79 | POLB (0.39) | MAPK1POLBCA4ALDH1A1KDM4E | |
| SCHEMBL28198895 | 0.78 | NR1H2 (0.36) | MAPK1POLBCA4ALDH1A1KDM4E | |
| SCHEMBL393508 | 0.77 | POLB (0.32) | MAPK1POLBCA4ALDH1A1KDM4E | |
| SCHEMBL17391477 | 0.77 | ESR1 (0.33) | MAPK1CA4ALDH1A1ALOX15TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9657039-B2 | Production method for alkoxysilanes | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2017-05-23 | — | — | US | disclosed |
| US-20160002271-A1 | PRODUCTION METHOD FOR ALKOXYSILANES | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2016-01-07 | — | — | US | disclosed |
| US-8993158-B2 | Nonaqueous electrolyte solution containing silyl ester group-containing phosphonic acid derivative, and lithium secondary battery | MITSUI CHEMICALS, INC. (JP) | 2015-03-31 | — | — | US | disclosed |
| US-20130071732-A1 | NONAQUEOUS ELECTROLYTE SOLUTION CONTAINING SILYL ESTER GROUP-CONTAINING PHOSPHONIC ACID DERIVATIVE, AND LITHIUM SECONDARY BATTERY | MITSUI CHEMICALS, INC. (JP) | 2013-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130071732-A1 | NONAQUEOUS ELECTROLYTE SOLUTION CONTAINING SILYL ESTER GROUP-CONTAINING PHOSPHONIC ACID DERIVATIVE, AND LITHIUM SECONDARY BATTERY | PHOSPHO1, PSPH, SGK2 | MAPK1 541/4885POLB 1105/4885CA4 345/4885 |
| US-20160002271-A1 | PRODUCTION METHOD FOR ALKOXYSILANES | MSMO1, MGAM, MACO1 | MAPK1 3351/4885POLB 1455/4885CA4 692/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.